A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bristol-Myers Squibb
Bristol-Myers Squibb
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Blacktown Hospital
Blacktown, New South Wales, Australia
Recruiting - Liverpool Hospital
Liverpool, New South Wales, Australia
Recruiting - Princess Alexandra Hospital
Brisbane, Queensland, Australia
Recruiting - Cabrini Hospital - Malvern
Malvern, Victoria, Australia
Recruiting - St Vincent'S Hospital
Melbourne, Victoria, Australia
Recruiting - One Clinical Research
Nedlands, Western Australia, Australia
Recruiting
- Cross Cancer Institute
Edmonton, Alberta, Canada
Recruiting - Local Institution - 0030
Vancouver, British Columbia, Canada
Completed - Hamilton Health Sciences-Juravinski Cancer Centre
Hamilton, Ontario, Canada
Recruiting - Local Institution - 0009
Toronto, Ontario, Canada
Completed - Centre Hospitalier de Luniversite de Montreal
Montreal, Quebec, Canada
Recruiting - Local Institution - 0016
Ottawa, Canada
Completed
- Local Institution - 0044
Ulm, Baden-Wurttemberg, Germany
Completed - Universitaetsklinikum Carl Gustav Carus Dresden-University Cancer Center Early Clinical Trial Unit
Dresden, Germany
Recruiting - Universitaetsklinikum Essen
Essen, Germany
Recruiting - Universitatsklinikum Frankfurt
Frankfurt, Germany
Recruiting - Universitaetsklinikum Wuerzburg
Würzburg, Germany
Recruiting
- Rabin Medical Center
Petah Tikva, Central District, Israel
Recruiting - Local Institution - 0035
Ramat Gan, Central District, Israel
Withdrawn - Sheba Medical Center
Ramat Gan, Central District, Israel
Recruiting - Rambam Health Care Campus
Haifa, Northern District, Israel
Recruiting - Sourasky Medical Center
Tel Aviv, Tell Abīb, Israel
Recruiting
- Humanitas
Rozzano, Milano, Italy
Recruiting - Istituto Di Candiolo Irccs - Fondazione del Piemonte Per L'Oncologia
Candiolo, Torino, Italy
Recruiting - Fondazione Irccs Istituto Nazionale Dei Tumori-Struttura Complessa Oncologia Medica 1
Milan, Italy
Recruiting - Istituto Nazionale Tumori Irccs Fondazione Pascale
Naples, Italy
Recruiting - Fondazione Policlinico Universitario Agostino Gemelli Irccs - Università Cattolica del Sacro Cuore
Roma, Italy
Recruiting - Ospedale Le Scotte-U.O.C. Immunoterapia Oncologica
Siena, Italy
Recruiting
- National Cancer Center Hospital East
Kashiwa, Chiba, Japan
Recruiting
- Hospital Universitario Virgen de la Victoria
Málaga, Andalusia, Spain
Recruiting - Institut Catalan D Oncologia (ico) - Badalona
Badalona, Barcelona [Barcelona], Spain
Recruiting - Hospital Universitari Vall D'Hebron
Barcelona, Barcelona [Barcelona], Spain
Recruiting - Hospital Universitario 12 de Octubre
Madrid, Madrid, Comunidad de, Spain
Recruiting - Centro Integral Oncologico Clara Campal-Hospital Hm Universitario Sanchinarro-Start Madrid-Ciocc
Madrid, Spain
Recruiting - Hospital Universitario Fundación Jiménez Díaz-Start Madrid-Fjd
Madrid, Spain
Recruiting - Clinica Universidad de Navarra-Oncology
Pamplona, Spain
Recruiting
- Community Cancer Institute
Clovis, California, United States
Recruiting - Usc/norris Comprehensive Cancer Center
Los Angeles, California, United States
Recruiting - Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
Recruiting - University of Iowa
Iowa City, Iowa, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 May 2021
- Primary completion
- 31 Aug 2031
- Completion
- 31 Aug 2031
- Last update posted
- 30 Jun 2026
- Registered enrollment
- 1,109
- Registry id
- NCT04895709
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.